ジャーナル論文 Impact of Lipid Bilayer Composition and Physicochemical Properties on Constitution of a Transmembrane Helical Peptide into Exosome-Mimetic Vesicles
Shiho Tsutsumi (author) (この著者で検索)
ORCID ;
Yuki Takechi-Haraya (author) (この著者で検索)
ORCID ;
Yasuhiro Abe (author) (この著者で検索)
ORCID ; ORCID SAMURAI
コレクション

引用
Shiho Tsutsumi, Yuki Takechi-Haraya, Yasuhiro Abe, Kohsaku Kawakami. Impact of Lipid Bilayer Composition and Physicochemical Properties on Constitution of a Transmembrane Helical Peptide into Exosome-Mimetic Vesicles. Molecular Pharmaceutics. 2025, 22 (11), 6874-6886. https://doi.org/10.1021/acs.molpharmaceut.5c00825

説明:

(abstract)

Exosomes are expected to efficiently deliver drugs, such as microRNAs and proteins, to targeted organs. However, using natural exosomes presents many difficulties in terms of safety, quality control, and manufacturing; therefore, developing exosome-mimetic artificial materials is desirable. In this study, we elucidated how sphingomyelin (SM) and cholesterol (CH), the
main constituents of the exosome membrane, in addition to phosphatidylcholine (PC), influence the physicochemical properties of PC vesicles. Then, the relevance of these properties to the secondary structure and insertion efficiency of a helical peptide, the transmembrane domain of integrin α, was investigated. The constitution of this peptide was most successful with exosome-mimetic vesicles (EMV) bearing 15 mol % SM and 40 mol % CH, and the exclusion of SM or CH resulted in low dispersion stability or
unsuccessful peptide constitution. Physicochemical analysis of the membrane properties revealed that successful peptide incorporation into the lipid membrane relied on the membrane softness induced by CH and the appearance of a highly mobile boundary phase induced by SM, which together created a favorable environment for the peptide. These results provide important insights that serve as a foundation for developing EMV as drug carriers.

権利情報:

キーワード: Exosomes, Exosome mimetic vesicles, lipid membrane, helical peptide

刊行年月日: 2025-11-03

出版者: American Chemical Society (ACS)

掲載誌:

  • Molecular Pharmaceutics (ISSN: 15438384) vol. 22 issue. 11 p. 6874-6886

研究助成金:

  • Japan Society for the Promotion of Science JP23K06092

原稿種別: 出版者版 (Version of record)

MDR DOI:

公開URL: https://doi.org/10.1021/acs.molpharmaceut.5c00825

関連資料:

その他の識別子:

連絡先:

更新時刻: 2025-11-25 12:30:04 +0900

MDRでの公開時刻: 2025-11-25 12:23:32 +0900

ファイル名 サイズ
ファイル名 2025MolPharm_EMV.pdf (サムネイル)
application/pdf
サイズ 4.42MB 詳細